A novel snake venom‐derived <scp>GPIb</scp> antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury

Abstract

Our data indicate anfibatide is a safe GPIb antagonist that exerts a protective effect on cerebral ischaemia and reperfusion injury. Anfibatide is a promising candidate that could be beneficial for the treatment of ischaemic stroke.